SCHEDULE OF INTANGIBLE ASSETS AND GOODWILL (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Oct. 31, 2017
Restructuring Cost and Reserve [Line Items]
Goodwill from N7 Acquisition	$ 3,014,450	$ 2,188,810
Total	$ 3,014,450	2,188,810
Phoenix Life Sciences, Inc. [Member]
Restructuring Cost and Reserve [Line Items]
Goodwill from Acquisition, Estimated Life	Tested Yearly for Impairment
Goodwill from N7 Acquisition	$ 2,188,810	2,188,810	$ 2,189,000
N7 Acquistion [Member]
Restructuring Cost and Reserve [Line Items]
Goodwill from Acquisition, Estimated Life	Tested Yearly for Impairment
Goodwill from N7 Acquisition	$ 825,640		$ 825,000